Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics
Open Access
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 48 (5) , 395-406
Abstract
Dependence of drug metabolism on dosing time has been long recognized. However, it is until recent years that the underlying mechanisms for circadian metabolism are being clarified. Diurnal rhythmicity in expression of drug-metabolizing enzymes is believed to be a key factor determining circadian metabolism. Supporting the general notion that biological rhythms are generated and maintained by the circadian clock, a number of diurnal enzymes are under the control of circadian clock. In general, circadian clock genes generate and regulate diurnal rhythmicity in drug enzymes via transcriptional actions on one or two of three cis-elements (i.e., E-box, D-box, and RevRE or RORE). Additionally, cycling or clock-controlled nuclear receptors such as Hnf4α and Ppar-γ are contributors to diurnal enzyme expression. These newly discovered mechanisms for each of rhythmic enzymes are reviewed in this article. We also discuss how the rhythms of enzymes are translated to circadian pharmacokinetics and drug chronotoxicity that has direct implications for chronotherapeutics. Our discussion is also extended to two diurnal transporters (P-gp and Mrp2) that have an important role in drug absorption. Although the experimental evidence is lacking in metabolism-based chronoefficacy, circadian genes (e.g., Rev-erbα) as drug targets are shown to account for diurnal variability in drug efficacy. SIGNIFICANCE STATEMENT Significant progresses have been made in clarifying the molecular mechanisms for generation of diurnally rhythmicity in drug-metabolizing enzymes. In this article, we review the newly discovered mechanisms for each of rhythmic enzymes, and discuss how the rhythms of enzymes are translated to circadian pharmacokinetics and drug chronotoxicity that has direct implications for chronotherapeutics.Keywords
This publication has 127 references indexed in Scilit:
- Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 PathwayJournal of Biological Chemistry, 2012
- Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transportersBiochemical Pharmacology, 2012
- Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CARAdvanced Drug Delivery Reviews, 2010
- Diurnal Regulation of MTP and Plasma Triglyceride by CLOCK Is Mediated by SHPCell Metabolism, 2010
- The Drug Transporter−Metabolism Alliance: Uncovering and Defining the InterplayMolecular Pharmaceutics, 2009
- Circadian rhythm disturbances in depressionHuman Psychopharmacology: Clinical and Experimental, 2008
- Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbαGastroenterology, 2008
- Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitionsNature Genetics, 2006
- PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissuesProceedings of the National Academy of Sciences, 2004
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002